- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Multiple sclerosis
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 323KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 51KB)
Glatiramer – March 2022
Glatiramer: Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled pen; Copaxone®
Last updated
1 July 2022